Feasibility Study of the FARAFLEX Mapping and PFA System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 250 participants.
Also called NCT06510556
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT06510556
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium, Croatia, Czechia, Italy
- Registry status
- Recruiting
Technical summary
Registry record NCT06510556. Non-randomized; no masking; primary purpose treatment. Start 2025-02-17 (actual); primary completion 2027-02-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Feasibility Study of the FARAFLEX Mapping and PFA System
- Acronym
- ELEVATE-PF
- Condition
- Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Condition
- Paroxysmal AF
- Intervention (Device)
- FARAFLEX Ablation Treatment
- Intervention (Device)
- ELEVATE-COR Sub-study
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct06510556- Content hash
e3a859610ff457121bbb4544d0fb4b485e86cf65eb20d086334cd89094754c44